A pharmacokinetic study comparing the biosimilar HEC14028 and Dulaglutide (Trulicity®) in healthy Chinese subjects
Abstract This study aimed to evaluate the pharmacokinetics (PKs), safety, and immunogenicity of the biosimilar HEC14028 compared to reference Trulicity® (dulaglutide) in healthy male Chinese subjects. This study was a single‐center, randomized, open, single‐dose, parallel‐controlled comparative Phas...
Saved in:
Main Authors: | Xianglei Gao (Author), Yujing Di (Author), Yuan Lv (Author), Yingcai Luan (Author), Yang Xiong (Author), Yuli Xu (Author), Yusheng Li (Author), Linfeng Guo (Author), Xiaoping Li (Author), Li Deng (Author), Yulei Zhuang (Author), Jie Hou (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A phase I study comparing the pharmacokinetics of the biosimilar (RD12014) with liraglutide (Victoza) in healthy Chinese male subjects
by: Ruirui Zhou, et al.
Published: (2022) -
Detection of Salmonella typhimurium ATCC 14028 in Powder Prepared Traditional Medicines Using Real-Time PCR
by: Alfi Sophian, et al.
Published: (2021) -
Lovastatin induces G1-phase synchronization of HEC-1-A cells and JEC cells
by: Huimin Shen, et al.
Published: (2013) -
Safety, Tolerability and Pharmacokinetics of the Serotonin 5-HT6 Receptor Antagonist, HEC30654, in Healthy Chinese Subjects
by: Xiaojiao Li, et al.
Published: (2021) -
Bullous pemphigoid triggered by dulaglutide: a case report and a review of the literature
by: Benedetta Sonego, et al.
Published: (2023)